Wiedemann-Beckwith syndrome, imprinting, IGF2, and H19: implications for hemihyperplasia, associated neoplasms, and overgrowth
- PMID: 7802016
- DOI: 10.1002/ajmg.1320520222
Wiedemann-Beckwith syndrome, imprinting, IGF2, and H19: implications for hemihyperplasia, associated neoplasms, and overgrowth
Comment in
-
Wiedemann-Beckwith syndrome, Wilms tumor, birth weight, and insulin-like growth factor 2.Am J Med Genet. 1995 Jul 17;57(4):640. doi: 10.1002/ajmg.1320570427. Am J Med Genet. 1995. PMID: 7573147 No abstract available.
Similar articles
-
Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome.Nat Genet. 2004 Sep;36(9):958-60. doi: 10.1038/ng1410. Epub 2004 Aug 15. Nat Genet. 2004. PMID: 15314640
-
Wiedemann-Beckwith syndrome: genomic imprinting revisited.Am J Med Genet. 1994 Aug 15;52(2):235-6. doi: 10.1002/ajmg.1320520223. Am J Med Genet. 1994. PMID: 7802017 No abstract available.
-
Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome.Nature. 1997 Oct 23;389(6653):809-15. doi: 10.1038/39797. Nature. 1997. PMID: 9349812
-
Molecular biology of Beckwith-Wiedemann syndrome.Med Pediatr Oncol. 1996 Nov;27(5):462-9. doi: 10.1002/(SICI)1096-911X(199611)27:5<462::AID-MPO13>3.0.CO;2-C. Med Pediatr Oncol. 1996. PMID: 8827075 Review.
-
Overgrowth syndromes and genomic imprinting: from mouse to man.Clin Genet. 1998 Mar;53(3):165-70. Clin Genet. 1998. PMID: 9630066 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous